Pharmaceutical Compositions and Pharmaceutical Products of Heterodimeric Human Interleukin-15 (hetIL-15)

Inventors

Ingo Fischer, Richard Gabriel

Assignees

1. Novartis AG

Abstract

The disclosure is directed to stable pharmaceutical compositions comprising a heterodimer complex of IL-15 and IL-15Rα and pharmaceutical products comprising such compositions. The disclosure is also directed to the use of these compositions (e.g. as part of a kit having instructions for use) and pharmaceutical products for the treatment of lymphopenia, cancer, or infectious disease.

CovalX Technology Used

HM4

Source